These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1267 related items for PubMed ID: 30021845

  • 1. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW, Lawler PR, Cook NR, Ridker PM, Mora S, Pradhan AD.
    Circulation; 2018 Nov 20; 138(21):2330-2341. PubMed ID: 30021845
    [Abstract] [Full Text] [Related]

  • 2. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR, Akinkuolie AO, Chu AY, Shah SH, Kraus WE, Craig D, Padmanabhan L, Glynn RJ, Ridker PM, Chasman DI, Mora S.
    J Am Heart Assoc; 2017 Jul 21; 6(7):. PubMed ID: 28733430
    [Abstract] [Full Text] [Related]

  • 3. Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease.
    Kou M, Ding N, Ballew SH, Salameh MJ, Martin SS, Selvin E, Heiss G, Ballantyne CM, Matsushita K, Hoogeveen RC.
    Arterioscler Thromb Vasc Biol; 2021 Mar 21; 41(3):1229-1238. PubMed ID: 33504178
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
    Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM.
    Diabetes; 2010 May 21; 59(5):1153-60. PubMed ID: 20185808
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ, Pittsburgh Epidemiology of Diabetes Complications Study.
    Diabetologia; 2003 May 21; 46(5):674-82. PubMed ID: 12743701
    [Abstract] [Full Text] [Related]

  • 6. Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density Lipoproteins.
    Lawler PR, Akinkuolie AO, Harada P, Glynn RJ, Chasman DI, Ridker PM, Mora S.
    J Am Heart Assoc; 2017 Dec 09; 6(12):. PubMed ID: 29223956
    [Abstract] [Full Text] [Related]

  • 7. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB, Akinkuolie AO, Paynter N, Glynn RJ, Ridker PM, Mora S.
    JAMA Cardiol; 2016 May 01; 1(2):136-45. PubMed ID: 27347563
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Kadota A, Kadowaki S, Kadowaki T, Yamamoto T, Miyagawa N, Zaid M, Torii S, Takashima N, Murakami Y, Okamura T, Horie M, Ueshima H, SESSA Research Group.
    Atherosclerosis; 2014 Oct 01; 236(2):237-43. PubMed ID: 25105580
    [Abstract] [Full Text] [Related]

  • 9. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
    Bertrand C, Saulnier PJ, Potier L, Croyal M, Blanchard V, Gand E, Ragot S, Schneider F, Bocock O, Baillet-Blanco L, Velho G, Marre M, Roussel R, Rigalleau V, Hadjadj S, Mohammedi K, SURDIAGENE Study Group.
    Diabetologia; 2021 Mar 01; 64(3):668-680. PubMed ID: 33409569
    [Abstract] [Full Text] [Related]

  • 10. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD.
    J Am Coll Cardiol; 2020 May 05; 75(17):2122-2135. PubMed ID: 32354380
    [Abstract] [Full Text] [Related]

  • 11. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug 05; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
    Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, Haffner SM.
    Circulation; 2005 Jun 28; 111(25):3465-72. PubMed ID: 15983261
    [Abstract] [Full Text] [Related]

  • 14. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
    Li R, Chen JX, Lu Q, Geng TT, Xia PF, Wang Y, Chen LK, Shan ZL, Pan A, Liu G.
    Diabetes Obes Metab; 2023 Nov 28; 25(11):3259-3267. PubMed ID: 37492984
    [Abstract] [Full Text] [Related]

  • 15. Paradoxical association of lipoprotein measures with incident atrial fibrillation.
    Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM.
    Circ Arrhythm Electrophysiol; 2014 Aug 28; 7(4):612-9. PubMed ID: 24860180
    [Abstract] [Full Text] [Related]

  • 16. High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease.
    Akinkuolie AO, Paynter NP, Padmanabhan L, Mora S.
    Circ Cardiovasc Qual Outcomes; 2014 Jan 28; 7(1):55-63. PubMed ID: 24248942
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
    Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM.
    Circulation; 2009 Feb 24; 119(7):931-9. PubMed ID: 19204302
    [Abstract] [Full Text] [Related]

  • 18. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
    Wojczynski MK, Glasser SP, Oberman A, Kabagambe EK, Hopkins PN, Tsai MY, Straka RJ, Ordovas JM, Arnett DK.
    Lipids Health Dis; 2011 Oct 18; 10():181. PubMed ID: 22008512
    [Abstract] [Full Text] [Related]

  • 19. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW, Warnick GR, Albers JJ, Hoover JJ, Walden CE, Bergelin RO, Ogilvie JT, Hazzard WR, Knopp RH.
    Atherosclerosis; 1981 Apr 18; 39(1):111-24. PubMed ID: 6941788
    [Abstract] [Full Text] [Related]

  • 20. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N, Ai M, Okazaki M, Ikezaki H, Ihara T, Hayashi T, Hiramine S, Ura K, Kohzuma T, Schaefer EJ, Hayashi J.
    Atherosclerosis; 2013 Dec 18; 231(2):238-45. PubMed ID: 24267234
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 64.